arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide has been researched along with Small Cell Lung Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalheiro, M; Corvo, ML; Cruz, MEM; Ferreira-Silva, M; Holovanchuk, D; Marinho, HS; Moreira, JN; Soares, H | 1 |
1 other study(ies) available for arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Antagonist G-targeted liposomes for improved delivery of anticancer drugs in small cell lung carcinoma.
Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Liposomes; Lung Neoplasms; Mice; Oligopeptides; Small Cell Lung Carcinoma; Tissue Distribution | 2022 |